Skip to content

Comparision study of drugs for symptom control and complication prevention of AF

Comparision study of drugs for symptom control and complication prevention of AF

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002011
Enrollment
7000
Registered
2016-08-17
Start date
2016-05-18
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients with atrial fibrillation ( patients with age more than 19 2. Patients who agree with study inclusion

Exclusion criteria

Exclusion criteria: 1. patients who do not agree with study inclusion 2. patients with age less than 19 3. Pregnancy, Breastfeeding 4. Atrial fibrillation patient of Artifical heart vavle

Design outcomes

Primary

MeasureTime frame
all cause mortality, hospitalization by heart farilure, recurrent stroke, cardiovascular events ,incidence of hemorrhage

Secondary

MeasureTime frame
complication of drug

Countries

Korea, Republic of

Contacts

Public ContactJeon Kyewon

Yonsei University Health System, Severance Hospital

cgc3@yuhs.ac+82-2-2228-8537

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026